Original news and analysis on international IP policy
A final decision on a World Trade Organization case over intellectual property rights protection between China and the United States was accepted by the states Friday, with both claiming its arbiter had affirmed their positions.
Bennett Lincoff writes: If Choruss abandons the time-tested approach of licensing and relies instead on covenants not to sue, it will facilitate a brazen money grab by the major labels it represents, leaving songwriters, recording artists and music publishers empty-handed, and college students holding the bag.
LYON, FRANCE – At the cutting edge of medical technology lie new hopes for patients, but also serious ethical concerns and potential intellectual property snags. Read More...
Santiago Roca escriba: La Unión Europea está solicitando mas extensiones en propiedad intelectual que los Estados Unidos de Norteamérica en la negociación del tratado de libre comercio.
With over 1 million patent applications backlogged at the US Patent & Trademark Office, IBM legal counsel Steven Bennett and David Kappos urge adoption of a deferred examination process, which they argue will benefit USPTO, applicants and the public.
On 3 March, 2009, bills were introduced in the US Congress setting forth the proposed "Patent Reform Act of 2009". The legislation proposes significant changes to post-issuance proceedings available to challenge patents in the United States. US attorneys Matthew A. Smith, Stephen B. Maebius and Jon W. Dudas argue the proposed legislation will be a step toward improving patent quality.
The United States patent reform bills offered up Tuesday fall well short of what is needed to protect innovation and intellectual property rights, say myriad small tech companies, large-cap manufacturers, pharmaceutical firms and inventors. In fact, they say, it even threatens jobs at a time when the economy is in desperate need of them.
But proponents argue that it is precisely the type of measure needed to promote jobs, reduce lawsuits and poor patent quality that put a drag on innovation and the economy.
Key players in the biotechnology industry are leading an effort to obtain global approval processes for generic biological medicines, which experts say could provide cheaper access to costly but widely prescribed and promising treatments.
As the United States battles an economic meltdown, items like economic stimulus and home foreclosure relief are taking centre stage. Congress also is still working to confirm President Obama's nominees. But once those items are dealt with, issues such as patent reform and intellectual property enforcement are expected to be hot-button items once again.
A small group of United States congressional staff and officials from the Obama administration working on intellectual property issues were in Geneva this week to discuss IP policy with representatives of intergovernmental organisations and industry, according to sources.